Filip K Knop Selected Research

Filip K Knop Research Topics

Disease

140	Type 2 Diabetes Mellitus (MODY) 10/2022 - 09/2003
28	Obesity 11/2022 - 01/2011
27	Insulin Resistance 04/2022 - 09/2003
27	Body Weight (Weight, Body) 01/2022 - 07/2008
24	Weight Loss (Weight Reduction) 04/2022 - 08/2009
24	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 09/2003
21	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 04/2010
20	Hyperglycemia 01/2022 - 01/2008
14	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2016
11	Overweight 01/2022 - 01/2011
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2013
9	Glucose Intolerance 01/2020 - 05/2011
8	Inflammation (Inflammations) 11/2022 - 11/2015
8	Schizophrenia (Dementia Praecox) 01/2019 - 08/2012
7	Bone Resorption 01/2022 - 11/2014
7	Weight Gain 12/2021 - 07/2008
6	Nausea 11/2020 - 08/2009
6	Chronic Pancreatitis 09/2010 - 09/2003
5	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2017
5	Diabetes Complications 09/2020 - 02/2009
5	Liver Diseases (Liver Disease) 07/2019 - 01/2018
4	Dyslipidemias (Dyslipidemia) 01/2022 - 09/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2016
4	Fibrosis (Cirrhosis) 02/2019 - 10/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2019 - 04/2014
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 12/2011
3	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2020 - 10/2013
3	Alcoholic Fatty Liver 07/2020 - 01/2017
3	Neoplasms (Cancer) 07/2019 - 11/2016
3	Vomiting 01/2017 - 10/2014
3	Pancreatitis 01/2017 - 01/2015
2	Cardiac Arrhythmias (Arrythmia) 12/2021 - 07/2021
2	Necrosis 01/2020 - 01/2018
2	Fatty Liver 01/2020 - 10/2019
2	Glucagonoma 07/2019 - 01/2017
2	Cholecystitis 01/2019 - 12/2018
2	Hyperplasia 01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

113	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 09/2003
63	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2021 - 09/2003
59	Glucagon (Glukagon)FDA Link 01/2022 - 01/2008
45	Insulin (Novolin)FDA Link 01/2022 - 09/2003
38	Hormones (Hormone)IBA 01/2022 - 12/2007
34	IncretinsIBA 12/2020 - 08/2007
29	Peptides (Polypeptides)IBA 10/2022 - 01/2007
25	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 08/2009
19	Liraglutide FDA Link 11/2021 - 05/2010
16	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 01/2008
12	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 12/2011
11	Exenatide (Byetta)FDA Link 01/2022 - 05/2010
11	Hypoglycemic Agents (Hypoglycemics)IBA 10/2021 - 07/2008
10	Glucagon Receptors (Glucagon Receptor)IBA 01/2022 - 01/2011
10	LipidsIBA 07/2020 - 05/2010
10	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 01/2014
9	Antipsychotic Agents (Antipsychotics)IBA 12/2021 - 08/2012
8	Amino Acids FDA Link 01/2022 - 01/2017
8	C-PeptideIBA 01/2022 - 05/2010
7	Pharmaceutical PreparationsIBA 07/2020 - 01/2010
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
5	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2022 - 01/2011
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 11/2016
5	gastric inhibitory polypeptide receptorIBA 01/2022 - 01/2019
5	lixisenatideIBA 03/2017 - 08/2009
4	Islet Amyloid PolypeptideIBA 04/2022 - 05/2010
4	CollagenIBA 05/2021 - 01/2018
4	Cholecystokinin (Pancreozymin)IBA 01/2021 - 11/2017
4	EnzymesIBA 01/2018 - 01/2007
3	Collagen Type I (Type I Collagen)IBA 01/2022 - 01/2020
3	semaglutideIBA 01/2022 - 03/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
3	Alanine (L-Alanine)FDA Link 12/2020 - 01/2018
3	Hepatocyte Nuclear FactorsIBA 01/2020 - 07/2014
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 03/2014
3	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 06/2014 - 01/2011
2	Sitagliptin Phosphate (Januvia)FDA Link 10/2022 - 01/2018
2	Islet Amyloid Polypeptide ReceptorsIBA 04/2022 - 01/2022
2	Calcitonin Receptors (Calcitonin Receptor)IBA 04/2022 - 01/2020
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2022 - 01/2020
2	adomeglivantIBA 01/2022 - 12/2020
2	FructosamineIBA 01/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 11/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021 - 01/2019
2	gastric inhibitory polypeptide (3-30)-amideIBA 05/2021 - 01/2020
2	fibroblast growth factor 21IBA 05/2021 - 01/2018
2	Sodium-Glucose Transport ProteinsIBA 12/2020 - 02/2016
2	glimepiride (Amarel)FDA LinkGeneric 01/2020 - 07/2014
2	Ethanol (Ethyl Alcohol)IBA 01/2020 - 10/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2020 - 10/2015
2	C-Reactive ProteinIBA 01/2020 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2017

Therapy/Procedure

24	Therapeutics 04/2022 - 09/2003
13	Glycemic Control 10/2022 - 12/2011
10	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 12/2011
5	Drug Therapy (Chemotherapy) 04/2022 - 11/2017
5	Subcutaneous Injections 01/2022 - 09/2003
5	Intravenous Infusions 01/2022 - 04/2016
4	Bariatric Surgery 02/2019 - 12/2011
3	Renal Dialysis (Hemodialysis) 01/2022 - 01/2020
3	Injections 01/2021 - 01/2010
3	Oral Administration 01/2018 - 04/2010